Posts by: Somi Igbene

People with Parkinson’s disease and rapid eye movement (REM) sleep behavior disorder — marked by acting out dreams, sometimes violently — showed no significant differences in their levels of tumor necrosis ... Read more

January 13, 2022January 14, 2022

CrCEST Imaging Tool May Detect Mitochondrial Function in Muscles

Friedreich's Ataxia News

Creatine chemical exchange saturation transfer or CrCEST, a metabolic imaging tool, may be a valuable technique for detecting mitochondrial function across muscles in people with Friedreich’s ataxia (FA), a new ... Read more

December 14, 2021December 14, 2021

Regular Eye Screening Vital for MS Patients, Study Finds

Multiple Sclerosis News Today

Visual disturbances are common in people with multiple sclerosis (MS), particularly among those with secondary progressive MS (SPMS), longer disease duration, and worse disability status, a new study has found. ... Read more

December 14, 2021December 14, 2021

ReS3-T Accepted Into Epilepsy Therapy Screening Program

Dravet Syndrome News

ReS3-T, an investigational medicine developed by reMynd for therapy-resistant epilepsies such as Dravet syndrome, has been accepted into the National Institute of Neurological Disorders and Stroke (NINDS) Epilepsy Therapy Screening Program ... Read more

November 24, 2021November 25, 2021

Progranulin Protein Levels in Blood May Predict AAV Severity

ANCA Vasculitis News

Blood levels of progranulin — a protein involved in cell development, cell growth, and wound healing — may predict the severity of ANCA-associated vasculitis (AAV), a new observational study suggests. ... Read more

November 22, 2021November 22, 2021

1st Patient Enrolled in Phase 1 Trial of Antibody Therapy BHV-1100

Myeloma Research News

Biohaven Pharmaceuticals has begun enrolling patients in its Phase 1a/1b trial testing the company’s antibody-recruiting molecule (ARM) called BHV-1100. The trial (NCT04634435) seeks to recruit 25 adults with newly diagnosed ... Read more

November 17, 2021November 18, 2021

Long-term Supplement Use May Improve Gait, Strength in RRMS

Multiple Sclerosis News Today

Long-term use of a high-dose nutritional supplement containing specific antioxidant vitamins and omega-3 and omega-6 fatty acids may boost walking performance and other measures of functional capacity in people with ... Read more

November 15, 2021November 15, 2021

Longer Breastfeeding May Damage Brain By Delaying DMT Use

Multiple Sclerosis News Today

Having at least one pregnancy may lower disability scores in women with multiple sclerosis (MS), but breastfeeding for longer than six months may worsen damage to the brain, an observational ... Read more

November 11, 2021November 11, 2021

Caregiver Burden in ALS Tied to Greater Anxiety, Disease Knowledge

ALS News Today

The burden of caregiving is heavier for people who are anxious and reasonably knowledgeable about amyotrophic lateral sclerosis (ALS), a study of patients and their caregivers in China suggests. The ... Read more

November 9, 2021November 9, 2021

Ianalumab, an Antibody, Eases Sjögren’s Symptoms at High Dose in Trial

Sjogren's Syndrome News

Ianalumab (VAY736), an investigational antibody to treat Sjögren’s syndrome, at high dose was well-tolerated by patients using it for one year, and led to reductions in disease activity and significantly greater ... Read more

November 8, 2021November 9, 2021

Repeat Kidney Biopsies May Help Better Determine Active Disease

ANCA Vasculitis News

After an initial biopsy shows signs of active ANCA-associated vasculitis (AAV) affecting the kidneys, repeat biopsies are better at determining active disease than standard measures of kidney function, a new ... Read more

November 5, 2021November 6, 2021

U.S. Researchers Invited to Apply for Ann Theodore Foundation Grants

Sarcoidosis News

A new grant program worth up to $3.5 million, from the Ann Theodore Foundation, is seeking researchers in the U.S. who are working to advance knowledge and understanding of sarcoidosis. ... Read more

November 3, 2021November 3, 2021

No Link Found Between Vitamin D Levels, Age at First MS Symptoms

Multiple Sclerosis News Today

There is no link between serum vitamin D levels and the age at which an individual develops the first symptoms of multiple sclerosis (MS), a new observational study suggests. However, ... Read more

November 2, 2021November 2, 2021

Compound Works to Ease Brain Inflammation Driven by Glial Cells

ALS News Today

A molecule that blocks the regulatory RNA protein HuR, called SRI-42127, strongly reduces brain inflammation driven by activated glial cells, key players in neurodegenerative diseases like amyotrophic lateral sclerosis, a preclinical study reported. ... Read more

November 2, 2021November 2, 2021

Loss of Smell Linked to Disease Severity

Sjogren's Syndrome News

Sensitivity to smell is reduced in people with Sjögren’s syndrome, compared with healthy controls, and appears to be linked to the severity of the disease, a new study reports. The ... Read more